Depression Clinical Trials in Tampa, FL

Depression Clinical Trials in Tampa, FL

View the best 10 depression medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Depression clinical trial.

Trials in Tampa, Florida

Here are the top 10 medical studies for depression in Tampa, Florida

Image of Neumora Investigator Site in Watertown, United States.

NMRA-335140 +1 More

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is studying the effects of a medication called NMRA-335140 on symptoms of depression in people with Major Depressive Disorder (MDD). The study will be conducted at multiple centers and will
Image of Benchmark Research in Shreveport, United States.

Placebo

Verified
Recruiting0 awardsPhase 2 & 3
A Phase 2/3 Trial is designed to evaluate SEP-363856 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
Image of Clinical Site in Pico Rivera, United States.

Lumateperone

Recruiting1 awardPhase 3
This trial is testing lumateperone, a medication that may help people with depression who haven't improved with other treatments. The study includes patients diagnosed with Major Depressive Disorder who haven't responded well to their current antidepressants. Lumateperone works by balancing brain chemicals that affect mood, potentially improving depressive symptoms.
Image of OMNI Medical Services in Boca Raton, United States.

Medical Cannabis

Cannabinoid

Recruiting1 awardPhase 2
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Image of Clinical Research Site in Bellflower, United States.

AXS-05

Behavioural Intervention

Recruiting3 awardsPhase 4
This trial is testing AXS-05, a new medication, to see if it can prevent depression from returning in people who have already improved with it. The study focuses on those with major depressive disorder and aims to maintain their balanced brain chemicals to keep them feeling better. AXS-05 (a combination of dextromethorphan and bupropion) has shown positive results in previous trials for major depressive disorder.
Image of Synexus – Atlanta in Sandy Springs, United States.

NMRA-335140

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing a new medication called NMRA-335140 to see if it can help people with severe depression. The study involves participants with Major Depressive Disorder and aims to find out if the medication can improve their mood by altering brain chemicals.
Image of Sheppard Pratt Health System in Baltimore, United States.

Psilocybin

Psychedelic

Recruiting1 awardPhase 3
This trial is testing a new medication called COMP360 to help people with severe depression that hasn't improved with other treatments. The study involves adults aged 18 and older. Researchers want to see if a single dose of COMP360 can reduce depression symptoms when given with psychological support.
Image of Gerbera site in Canoga Park, United States.

NORA520

Medication

Recruiting0 awardsPhase 2
This trial is testing a drug called NORA520 to see if it can help women with severe postpartum depression. The study will check how well the drug works, its side effects, and how much of it gets into the blood and breastmilk. Women in the study will take the drug for a short period.
Image of Site 4082 in Oceanside, United States.

ALTO-203

Procedure

Recruiting0 awardsPhase 2
This trial aims to study the effects of ALTO-203 in patients with Major Depressive Disorder (MDD) through two treatment periods. In the first period, participants will receive a single dose of
Image of Lauren Elizabeth Oberlin in New York, United States.

Targeted Cognitive Training Intervention

Behavioral Intervention

Recruiting1 award
This trial tests a digital brain training program for older adults with depression-related apathy. The program is expected to improve brain connections and reduce apathy symptoms by enhancing cognitive control.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.